Indication

Neonatal bronchopulmonary dysplasia

Neonatal bronchopulmonary dysplasia is a serious chronic respiratory disease that primarily develops in preterm infants, particularly those born at very low birth weight who require prolonged mechanical ventilation and supplemental oxygen therapy for infant respiratory distress syndrome. Read more about Neonatal bronchopulmonary dysplasia

10 drugs 9 manufacturers

Advertisement

Drugs that treat it

Common Neonatal bronchopulmonary dysplasia therapies.

Showing 1–9 of 10 drugs

Filter & compare in the drug finder →Opens the drug finder with Neonatal bronchopulmonary dysplasia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Neonatal bronchopulmonary dysplasia.

Neonatal bronchopulmonary dysplasia is a serious chronic respiratory disease that primarily develops in preterm infants, particularly those born at very low birth weight who require prolonged mechanical ventilation and supplemental oxygen therapy for infant respiratory distress syndrome.

It is pathophysiologically characterized by arrested lung development, resulting in alveolar simplification, dysmorphic microvasculature, and variable airway inflammation and fibrosis triggered by barotrauma, hyperoxia, and inflammatory injury to the immature pulmonary parenchyma.

Clinically, affected neonates demonstrate persistent oxygen dependency beyond 28 days of life or at 36 weeks postmenstrual age, often accompanied by tachypnea, retractions, wheezing, and impaired gas exchange.

Personalize your experience

Follow Neonatal bronchopulmonary dysplasia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it